Research and development

At Hikma, our R&D teams are dedicated to delivering high-quality medicines, that reach millions of patients across North America, Europe, and the MENA region. Three key locations power our global network. Ensuring rapid product development and market introduction. We operate three technology platforms; Injectables, Respiratory, Nasal Semi-Solids and Liquids and Oral Solids.

They are supported by global R&D operations including project management, device development, extractables and leachables and nitrosamine laboratory services and Regulatory Affairs. Our API manufacturing facility and independent clinical contract research organisation (IPRC) also support our development teams.

Every R&D programme brings together leading formulation and analytical researchers clinical and non-clinical experts and project managers for outstanding delivery. Our integrated approach connects R&D with product selection intellectual property and operations, driving faster, smarter development.

Our key R&D Injectables expertise is located in Zagreb, Croatia and in Jordan. Our cross-functional teams develop generic and differentiated injectable products. They are supported by dedicated teens to ensure rapid manufacturing introduction.

We deliver diluted and stable products that are ready to be administered the moment patients need them and we continue to advance our expertise to become the leader in complex injectable development.

In our respiratory nasal semi-solids and liquids are R&D hub in Columbus, we develop a range of complex combination products. Our teams are highly skilled in complex state-of-the-art formulation, analytical techniques and clinical research. Automation is embedded in our development process, which increases speed and drives better quality.

R&D for oral solids is located in Jordan and Columbus. Our teams work closely together to develop formulations across multiple therapeutic areas including oncology for all our markets. We use advanced technology and keep building on our oral solids expertise to develop the medicines that patients need.

Our Regulatory Affairs teams collaborate with regulatory agencies to secure product approvals that support our growth, expand up portfolio, and enhance our manufacturing capabilities.

Across all three of our platforms, we collaborate with partners so that we can harness new technologies and bring more complex products to market faster. Ultimately, everything we do is driven by our commitment to Quality. Our rigorous processes ensure regulatory compliance delivering medicines that patients and healthcare providers trust. Our R&D teams around the world are dedicated to achieving this goal. Together, we aim to put better health within reach, every day.